Target prices in the $36.00−$39.00 range: These firms believe that there are a number of headwinds facing the firm next year. These include continued levels of high unemployment, state budget pressure on government business, the phase-down of increased Federal Medical Assistance Percentage (FMAP) funding, further declines in Medicare Advantage reimbursement along with a compressed enrollment period, increased expenses related to IDC-10 coding and Health Insurance Portability and Accountability (HIPAA) 5010 compliance, the likely elimination of the favorable prior period reserve development seen in 2010 as utilization is expected to normalize, as well as the impacts from health reform including new coverage requirements, benefits changes and minimum medical loss ratio (MLR) provisions.
| |